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684 The Journal of Thoracic and CardioObjective: This was an evaluation of a new approach to the management of multiple
muscular ventricular septal defects. The defects were located with epicardial echo-
cardiography, then transfixed with a guide wire inserted directly through the right
ventricular free wall. They were closed with a custom-made multilayered double-
patch device under cardioplegic arrest through a standard right atriotomy.
Methods: This was a retrospective study of 14 consecutive patients.
Results: The median age and body weight at repair were 40 days (range 1 week–8
years, 3 months) and 4.1 kg (2.8-24 kg), respectively. Five patients (36%) had
undergone at least one previous sternotomy; 11 patients (78%) had associated
cardiac lesions. Closure of the multiple septal defects was successful in 12 patients
(85%). Failure to localize all defects led to pulmonary artery banding in 2 patients.
One patient had the residual septal defect closed with a percutaneous device 6
months later, and in the second patient the residual defect was closed with a
conventional approach 11 months afterward. Two patients had permanent pace-
maker insertion. In 279 patient-months of follow-up, there was 1 cardiac arrest on
day 1 and no early or late deaths; all children but one are free of cardiac medications,
and no significant residual left-to-right shunts were demonstrated in any patient.
Conclusion: The reported management of multiple ventricular septal defects has
been successful in this series, even in neonates and infants with complex associated
cardiac lesions. It appears safe, simple, and effective.
The management of patients with multiple ventricular septal defects(VSDs) remains a surgical challenge, with primary surgical repair toavoid palliation increasingly favored.1-3 In the neonate and infant,primary repair can be demanding. The intraoperative identificationof muscular defects is difficult through the right atriotomy. Often thisrequires long aortic crossclamp and cardiopulmonary bypass (CPB)
times and right or left ventriculotomies. Left ventriculotomies have long-term
complications.4,5 Eventually some VSDs may never be found, despite extensive
resection of muscular trabeculations, and may generate large residual shunts. Al-
ternately, the initial palliation with pulmonary artery banding has inherent morbidity
vascular Surgery ● November 2004
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DTABLE 1. Surgical characteristics of the 14 patients undergoing closure of multiple VSDs
Case
Associated
lesions Previous interventions
Age at
repair Surgical procedures
Discharge transthoracic
echocardiographic findings
1 Coarctation (1) Coarctation repair plus
PAB; (2) PA debanding,
patch closure of one VSD
4 y, 7 mo Closure of midmuscular VSD
(device), apical VSD (device);
apical ventriculotomy
Remaining apical VSD; no
significant shunt; progressive
severe dilated cardiomyopathy
2 None (1) PDA ligation plus PAB;
(2) Exploration after
cardiac perforation in
catheter lab
8 y, 3 mo Closure of perimembranous
VSD (suture), apical VSD
(device); apical
ventriculotomy
Two minimal residual shunts; good
LV function
3 AVSD (1) PAB; (2) AVSD repair
plus PA debanding
2 y Closure of midmuscular VSD
(device); trivial apical VSD
not approached
Small apical VSD; no shunt over
patch; good LV function
4 TGA BAS 7 d ASO plus closure of
midmuscular VSD (suture)
plus closure of midmuscular
VSD (device)
Minimal shunt over remaining
muscular VSD; good LV function
5 TGA, LVOTO BAS 9 d ASO plus LVOTO resection plus
PAB; midmuscular VSD could
not be localized
Two small muscular VSDs,
bidirectional shunt; after VSD
closure with Amplatzer device,
no shunt and good LV function
6 TGA BAS 1 mo ASO plus closure of high
muscular VSD (device)
Remaining small apical VSD; no
shunt over addressed VSD; good
LV function
7 None PAB 6 y, 1 mo Closure of 3 trabecular VSDs
(apical, 3 devices); apical
ventriculotomy; 2 separate
crossclamps
No shunt; good LV function
8 Coarctation Coarctation repair plus PAB 1 y, 4 mo Closure of apical VSD
(2 devices) plus PA
debanding
Small residual apical VSD (velocity
3.6 m/s); good LV function
9 Truncus
arteriosus
29 d Truncus repair (12-mm
homograft); apical VSD
(device); subarterial VSD
patch
Angiography pulmonary/systemic
perfusion ratio 1:1
10 DORV,
LVOTO
PAB 42 d DORV repair; SAS resection;
closure perimembranous
VSD (patch); closure high
anterior trabecular VSD
(device)
No residual shunt; good LV
function
11 TGA 60 d ASO; 2 muscular VSDs closed
(devices); 1 muscular VSD
left (banded)
Good LV function; no shunt at 4
mo
12 TGA 11 d ASO; perimembranous VSD
patch; muscular VSD device
(2 crossclamps)
No shunt; good LV function
13 Coarctation Coarctation repair 38 d Inlet VSD patch, anterior
muscular device
Trivial shunt; good LV function
14 Hypoplastic
arch
Extended arch repair 26 d 2 midmuscular VSDs (2
devices, 2 crossclamps);
apical VSD direct suture;
apical ventriculotomy;
cardiac arrest 18 h; ECMO
Trivial shunt; good LV function;
bronchomalacia
PAB, Pulmonary artery banding; PA, pulmonary artery; PDA, patent ductus arteriosus; AVSD, atrioventricular septal defect; TGA, transposition of the great
arteries; BAS, balloon atrioseptostomy; ASO, arterial switch operation; LVOTO, LV outflow tract obstruction; DORV, double-outlet RV; ECMO, extracorporeal
membrane oxygenation; SAS, subaortic stenosis.
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Dand significant technical drawbacks in the presence of major
associated cardiac defects. Other alternatives include cath-
eter-delivered VSD devices. The VSDs need to match strict
anatomic exclusions criteria, however, and the delivery sys-
tem is unsafe in neonates and young infants.
We report a technique in which the difficulties of the
management of multiple VSDs are addressed: intraoper-
ative recognition of the VSDs, direct location of the
VSDs, and simple and effective closure without left
ventriculotomies. The technique is described, together
with follow-up data.
Patients and Methods
Patients
Fourteen consecutive children were operated on during a 36-month
period from February 2000 to February 2003. The indication was
multiple muscular VSDs, regardless of the presence of other car-
diac defects. All parents gave written, informed preoperative con-
sent. Median age at final repair was 40 days (range 1 week–8
years), and median body weight was 4.1 kg (2.8-23.9 kg). Five
patients (36%) had a previous sternotomy with placement of a
Figure 1. Schematic step-by-step implantation of device.pulmonary artery band or other procedures (Table 1). Eleven
686 The Journal of Thoracic and Cardiovascular Surgery ● Novepatients had associated cardiac defects (78.5%). In 3 patients a
coarctation had been previously repaired through a left thoracot-
omy; 1 underwent banding simultaneously.
Intraoperative VSD Recognition, Pinpointing, and
Closure (Figure 1)
Before the operation, circular composite patches of various diam-
eters, with an outer layer of knitted polytetrafluoroethylene (PTFE,
Bard Edwards Outflow Tract Fabric; IMPRA, Tempe, Ariz) and an
inner layer of thick, soft PTFE felt (Bard PTFE Felt; IMPRA) were
prepared. The two components were sutured together circumfer-
entially and sterilized. The final appearance of the patch is illus-
trated in Figure 2. During the operation, the diameter of the chosen
patches was according to the echocardiographic measurements and
the number of VSDs to cover.
Under moderate hypothermic (34°C) CPB and some volume
loading to gently distend the heart and the septum, an epicardial
echocardiographic study (Agilent Sonos 5500 with 12-MHz S12
probe; Forest Hill, Victoria, Australia) was performed to localize
the VSDs. Once identified, the largest or most central muscular
VSD channel was traversed directly through the right ventricular
(RV) free wall (Figure 3). In the 9 nine cases, a flexible guide wire
was used (0.018 inch in diameter, 40 cm long; Cook Group
Incorporated, Bloomington, Ind), whereas in the first 5 patients in
the series, a 3F Fogarty catheter was used (Applied Medical,
Laguna Hills, Calif). The inflated balloon of the catheter secured
the position in the left ventricle (LV). Guide wires were sutured in
position on the RV. If remaining VSDs were remote, they were
addressed in a similar fashion. If the VSD could not be traversed,
the guide wire was secured in a position exactly at the RV ostium
of the VSD. Once the VSDs were pinpointed, the heart was
drained, the temperature was lowered (32°C), and the aorta was
crossclamped. Antegrade cold blood cardioplegia was used. The
guide wire in the RV was seen through the tricuspid valve, dem-
onstrating the main muscular VSD. Then a right-angled instrument
was introduced into the VSD from the RV side. The tip could be
seen in the LV through a perimembranous VSD (if present),
Figure 2. Custom-made patch with the braided mattress suture
inserted. There are two layers: woven Dacron polyester fabric on
cameral aspect of patch and thick, soft PTFE felt on endocardial
aspect.through the mitral valve, or through the transected main pulmonary
mber 2004
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Dartery, depending on the approach to coexisting defects. A silicone
tape, secured to a 2-0 (or 3-0) mattress suture mounted onto the
prepared patch, was grasped and pulled back into the RV, seating
the patch snugly to the LV side of the septum. The sutures were
threaded through an identical patch. The second patch was tied
down to the RV aspect of the septum, thus sandwiching the VSDs.
This could be done either through the tricuspid valve or, with
apical VSDs, through a small, purpose-made RV incision. When
several VSDs were in close relation, they were collectively closed
with oversized patches. For distant VSDs, to avoid very large
patches and plastering of the septum, separate double patches were
used. Coexisting cardiac lesions were addressed. After CPB, the
VSD closure was assessed with epicardial echocardiography to
detect a residual left-to-right shunt, and simultaneous blood sam-
ples were taken from the right atrium and pulmonary artery to
calculate the magnitude of such a shunt.
After the operation, all patients had at least one transthoracic
echocardiographic study performed before discharge. Continued
follow-up and medical management were at the discretion of the
referring pediatric cardiologist.
Statistics
Results for the continuous variables are presented as median and
range; proportions are expressed with 95% confidence intervals,
with continuity correction for the upper and lower limits of the
latter.
Results
The surgical characteristics of the patients, the anatomy of
the septum, the procedures performed, and the discharge
echocardiographic findings are given in Table 1. Median
aortic crossclamp time was 100 minutes (range 39-180
minutes); median CPB time was 170 minutes (68-269 min-
Figure 3. Epicardial intraoperative echocardiographic
repair demonstrates anterior muscular VSD; VSD is trautes). A total of 33 VSDs were diagnosed preoperatively
The Journal of Thoraciand intraoperatively; of these, 7 were apical. Five VSDs
were closed with conventional patches and interrupted pledget-
supported sutures, 3 were closed directly, and 6 were left open.
Nineteen devices were used, 5 in the apical septum. One
patient had 3, another 4 patients had 2, and 1 patient had none,
because the VSD was recognized but not adequately pin-
pointed. Six small right apical ventriculotomies were used and
closed directly. There were no in-hospital deaths and no deaths
during a total of 279 patient-months of follow-up (median 16
months, range 7-41 months). Two patients (cases 5 and 12) had
arterial switch and multiple VSD closure. They required pul-
monary arterial banding for residual shunting outside the area
of the devices. In case 5, the residual VSD was successfully
closed percutaneously with an Amplatzer device 6 months
later, followed by debanding 3 days after that. Patient 5 also
had simultaneous resection of LV outflow tract obstruction and
required pacemaker implantation. He subsequently recovered
sinus rhythm. In patient 12, the residual VSD was closed 11
months postoperatively through a standard approach and the
pulmonary artery was repaired. Patient 14 had a hypoplastic
aortic arch repaired in the neonatal period. Multiple apical
muscular VSDs required closure 2 weeks later. During the
operation, multiple trabecular VSDs were demonstrated and
required two additional crossclamp applications to achieve
septation. Cardiac arrest occurred 18 hours postoperatively,
and extracorporeal membrane oxygenation was instituted.
Weaning from the assist device occurred on day 9. A complete
AV block required pacemaker implantation. Two months post-
operatively, there was no shunt, and ventricular function was
good with normal conduction. Patient 1 has shown progressive
in patient with transposition of great arteries before
ed with guide wire.studydevelopment of dilated cardiomyopathy, and eventually typical
c and Cardiovascular Surgery ● Volume 128, Number 5 687
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Dnoncompacted LV was diagnosed. All other patients are well
and free of cardiac medications. In all 14 patients, there is no
evidence of significant left-to-right shunt at latest echocardio-
graphic study.
Discussion
With conventional techniques, the complications of this
surgery are mostly significant residual shunts, need for
multiple reoperations, and severe LV dysfunction. High
mortality risks are quoted. There are several aspects adding
to the difficulties in the management of multiple muscular
VSDs.
In the neonate and young infant, VSDs can be difficult or
impossible to identify intraoperatively. Through the tricus-
pid valve, in the search for the VSD, extensive division of
muscular trabeculations and bands, including the moderator
band, may be performed. These divisions compromise RV
function substantially. A small apical RV incision, precisely
targeted, can be valuable. It allows fast, accurate, and safe
placement of the patch. This emphasizes the necessity to
know exactly where the VSDs are. Alternately, several
incisions in the quest of the VSDs, together with their
closure, if extensive or ill placed, could cause considerable
damage. The surgical exposition gained through left ventri-
culotomies can be disappointing. The leftward aspect of the
Figure 4. Decision tree for surgical treatseptum is not free of trabeculations and may be heavily
688 The Journal of Thoracic and Cardiovascular Surgery ● Novetrabeculated at the apex. Moreover, left ventriculotomies are
considered by some to be associated with unacceptable
long-term risks, including aneurysm formation, LV dys-
function, and ventricular arrhythmia.4,5
For most teams, catheter-delivered devices are not rec-
ommended in this age group. The stiffness of the guide wire
but especially of the sheath is responsible for rupture of the
mitral valve, tearing of the septum, severe dysrhythmia, and
cardiac arrest during the procedure.
Initial palliation with a pulmonary artery band has inher-
ent morbidity and mortality and requires two stages. The
added complexity during the second stage includes pericar-
dial adhesions, need for pulmonary artery repair, damage to
the potential neoaortic valve, and RV hypertrophy contrib-
uting to the difficult location and closure of the VSDs.1-3 In
many of our neonatal patients, a simple palliation would
have been ill advised because of the potential for damage to
the pulmonary valve in the nonrepaired transposition or for
damage to the conduit in a repaired truncus arteriosus.
Often, undiagnosed additional small VSDs without de-
tectable shunting in the presence of a larger VSD may be
unmasked after repair and contribute to a significant resid-
ual left-to-right shunt. The technique presented here deals
with these issues.
of muscular VSD. PA, Pulmonary artery.In our series, the technical difficulties were of five types:
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D1. The size of the probe did not allow simple apical
4-chamber views without significant disruption of
the ventricular geometry. Only transverse cuts and
longitudinal view could be obtained with the heart in
the pericardial cavity. We prefer epicardial echocar-
diographic study, because transesophageal probes
give poor views of the apex and in our experience
have not been useful for apical VSD location. More
importantly, we consider the direct handling of the
epicardial probe by the operator in itself useful for
the location of VSDs. Under CPB, it is easier and
more informative because the VSD shunting is in-
creased. The lowering of the temperature slows the
heart rate. The heart can be distended gently with the
modulation of the venous drainage and can be ma-
nipulated safely.
2. Even when adequately located, the main VSD chan-
nel can be difficult to transfix.
3. In 2 cases the initial appreciation of the size of the
VSD was inadequate, resulting in the insertion of
undersized patches. In both cases this had to be
corrected with another application of the crossclamp
and replacement of the patches with larger ones.
4. Some muscular VSDs are only visible or hemody-
namically significant after closure of the other VSDs
(patients 7 and 11).
5. Crossclamp times have been long, but these were in
relation to complex associated lesions. Each individ-
ual double-patch device placement was fast, and the
procedure can be done in 10 to 15 minutes. Place-
ment of multiple devices does take time. Patient 14,
who had considerable morbidity, needed three cross-
clamp applications but had a cumulative crossclamp
time of 73 minutes. This emphasizes the need for
safe and reliable myocardial protection.
Despite these practical limitations, the technique was used
in 9 neonates and young infants weighing 2800 to 4100 g, 7 of
whom underwent simultaneous complex cardiac repair. No LV
incisions were used, and the apical RV incisions when required
have been minimal. If the 2 patients with intraoperative band-
ing are set aside, there was evidence of residual left-to-right
shunting detected at postoperative studies in 6 patients. These
shunts were not considered of significant magnitude. Two
patients had postoperative catheter studies. The pulmonary to
systemic perfusion ratios were 1.6:1 and 1:1. The only child
with symptoms (patient 1) was slightly exercise limited but has
evidence of severe dilated cardiomyopathy most likely not
related to the surgical procedure (crossclamp time 45 minutes).
Generally, the tiny shunts have tended to subside further with
continuing follow-up.
Several surgical managements of multiple VSDs have
been described. Kitagawa and colleagues1 used different
techniques in 33 patients, one of which relies on the concept
The Journal of Thoraciof an oversized patch placed on the LV side of the septum.
Sutures were placed circumferentially through the patch and
the rim of the VSD from the LV side. Obviously, this
method requires adequate localization and visualization of
the VSD during aortic crossclamping and numerous sutures
to be brought out from the LV, properly organized and tied.
Five patients (15%) required reinterventions for residual
VSD; early mortality was 3%. In 29%, a left ventriculotomy
was used, without, however, evidence of LV dysfunction at
midterm follow-up. Kapoor and associates6 used a simpli-
fied sandwich patch closure in 5 patients. They used a
right-angled instrument to probe the septum from the LV
side, depending on the presence of a sizeable perimembra-
nous VSD for introduction of the instrument. No follow-up
data were given, and the patients were significantly older.
Recently, Ootaki and collaborators7 presented a series of 11
patients treated with a similar technique, sandwiching the
septum between two felt patches. A total of 25 VSDs were
present, and 15 were closed with the sandwich technique.
The mean age was greater than in our series, and 9 of the 11
had primary palliation. Morbidity was not reported. Their
report adds credit to the safety of the method. For both of
these reports, however, the main difference from the tech-
nique described in this report is the absence of epicardial
echocardiography and means of precise location of the VSD
before ischemic arrest. We found that even in the few
instances in which none of the VSDs were transfixed, hav-
ing spent sufficient time trying to localize the VSD and
using all benchmarks available (trabeculae septomarginalis,
tricuspid annulus, aortic valve, acute angle of the anterior
septum with the anterior free wall of the RV, direction of the
probe), as well as using the guide wire inserted in front of
the RV main orifice of the VSD was extremely helpful in
the location. Probing the septum with instruments, espe-
cially in neonates’ and infants’ hearts, can be misleading
and create communications where they do not exist. Macé
and colleagues,8 as well as Black and coworkers,9 obliterate
the VSDs by extensive patching of the RV side of the
septum with a single8 or several9 patches. Operative and
follow-up mortalities were zero in both series, and no rein-
terventions for residual shunts were required. Neither group
reported experience with their technique in neonates. Macé
found septal motional abnormalities in all patients. In that
respect, we believe that our approach with two or more
separate devices rather than one very large device better
preserves the function of the septum.
Intraoperative placement of occluding devices designed
to be delivered percutaneously has been achieved experi-
mentally10 and clinically.11,12 In a series of 10 animals,
muscular and perimembranous VSDs were closed under
epicardial echocardiographic guidance, without CPB.10
This study inspired the development of the surgical strategy
described here. On follow-up, all muscular VSDs and 60%
c and Cardiovascular Surgery ● Volume 128, Number 5 689
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Dof perimembranous VSDs remained closed, at the expense
of aortic regurgitation in 1 animal. Since our current series
was completed, we ourselves have used this approach suc-
cessfully in 4 patients with isolated single midmuscular
VSD.
In their seminal study, Fishberger and associates11 at-
tempted to seal the VSD with catheter-bore occluding de-
vices placed intraoperatively with CPB and crossclamping.
Eight patients had complex lesions; 2 had isolated multiple
VSDs. The 2 patients with isolated VSDs required reinter-
ventions, and the overall mortality was 50%. A more recent
experience from Toronto12 quoted an early mortality of
14% in 14 patients. The overall mortality (including 1 late
heart transplant) was 28%, and the reoperation rate was
21%. The concept of VSD closure with devices designed for
catheter delivery but intraoperatively and with CPB is chal-
lenged by the present series. It has little advantage in terms
of simplicity and crossclamp time. The clinical results are
not convincing. It also carries substantial equipment costs.
The patches used in this series are inexpensive. They are
2-layered, with a softer PTFE component on the septal side,
effectively molding around the VSD, and a stiffer Dacron
polyester fabric component on the ventricular side, provid-
ing strength and allowing incorporation into the endocar-
dium.
Larger studies focusing on outcome2,3 have reported
reoperations for residual VSDs in 6% to 13%, and in one
series there was a 7.7% 30-day mortality.3 Importantly,
several studies1-3 emphasize the merits of primary surgical
repair.
In their proposition to treat coarctation complex in neo-
nates with absorbable pulmonary artery band applied at the
time of the coarctation repair, Bonnet and associates13
spared VSD closure altogether in 10 of 11 patients. Retro-
spectively, it is interesting to note that the only patient who
had severe morbidity in our series (patient 14) belongs to
this group of coarctation complex and would most likely
have benefited from this alternative technique. Again, since
this current series was completed, we ourselves have used
absorbable bands in 3 selected patients.
A decision tree was designed to integrate this series into
the general approach to the treatment of muscular VSDs in
our unit (Figure 4).
Limitations
The limitations are those of any small, observational, retro-
spective study. Therefore no statistically founded inferences
can be made at this point, and caution should be exercised
in any comparisons. However, the main objective was to
evaluate safety and feasibility of a novel management strat-
egy. Notably, it is founded on well-established clinical
techniques and equipment.
690 The Journal of Thoracic and Cardiovascular Surgery ● NoveConclusion
We believe this technique is a simple, safe, effective, cost-
conscious, and reproducible means of dealing with multiple
muscular VSDs in a wide range of settings, in particular
complex neonatal cases. In our early experience there have
been no deaths. Only in 2 instances was there inability to
locate a target VSD, and eventually all patients were fully
septated. This method may prove especially valuable in
complex cases in which there is a need to avoid time-
consuming procedures while aiming for primary repair of
VSDs in infancy.
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Discussion
Dr Brizard. We have learned from Dr Bove’s articles and expe-
rience.
First, I would like to acknowledge the other teams that have
used this technique before us, namely the sandwiching of the
septum, and also to acknowledge the team in Chicago, who trig-
gered the idea of perforating the RV and pinpointing the VSD with
a guide wire. That was experimental work several years ago.
mber 2004
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DThe first question was related to which patients we consider
suitable for a pulmonary artery banding.
The coarctation complex represents a group of patients in
whom the balance between the risk of complete closure in the
neonatal period and pulmonary artery banding have to be carefully
weighed. It is quite often that you can see these patients having
closure of their VSDs as an effect of a pulmonary artery band.
The team in Paris has reported the usage of an absorbable band,
and in 10 out of 11 patients they managed to see the spontaneous
closure under the effect of banding and without the need for
reoperation. In a group of patients with coarctation complex, this
strategy has to be carefully weighed.
The second question was whether the patches were too small,
and how to evaluate the size of the patch.
We have tried not to use too big patches, not to plaster the
septum completely. So initially we tried to use just the minimal
size patches, just over the size of the VSD as demonstrated on
echocardiography. But the size demonstrated on echocardiography
is not reliable at all, and we found that on 2 occasions the patches
were significantly undersized and were joined together on the
control echocardiography and were not appropriately stabilized.
On which occasion do we use more than one patch? If the VSDs
are far apart at the time of the preoperative echocardiography, we
use two patches.
I don’t have the figures well in mind at present, but I think on
2 occasions we had to replace the band. On 1 occasion we had to
replace the crossclamp and to close an additional VSD that was not
diagnosed at the time of the preoperative echocardiography.
Now as to the apical VSD, what we call an apical VSD is not
just any that is lower than the moderated band. Some of these
VSDs are still accessible from the tricuspid valve. We really call
the apical VSD those that are only accessible from the apex of the
RV.
I agree that sometimes when the apex of the LV is forming the
apex, a left ventriculotomy, or differently speaking a strictly apical
ventriculotomy but in fact inside the LV, may be more appropriate.
Often in these patients there is almost no left anterior descending
coronary artery at this site, and it doesn’t make much difference in
fact.
Dr Olsson. I would just like to clarify one thing from Dr
Bove’s comment.
Of the 2 patients mentioned here as having failures, in only 1
instance was it actually a failure to localize the VSD in a neonate
with a transposition. The other case had two patches to close, two
areas of the shunting; then, after removal from CPB, echocardi-
ography demonstrated a third area that had by then been un-
masked. In that situation, it was decided not to go back and
crossclamp again to address that area, because it was a complex
switch operation, and pulmonary arterial banding was chosen in
that case.
Dr Zahid Amin (Omaha, Neb). The technique of advancing
the wire under echocardiographic guidance through the RV free
wall was introduced by us about 5 years ago while I was in
Chicago, and we demonstrated that it was feasible to use in
animals and then in human beings.
The only difference between your technique and our technique
is that we did not place the patient on CPB at all. We used the wire
to advance a sheath over the wire and then used a self-expandable
The Journal of Thoracilate model device to close the VSDs. I call this technique “per-
ventricular closure of VSDs.” We have extended this technique
even to perimembranous VSDs. I believe that the most important
feature of this technique is avoidance of CPB, which helps to
decrease the morbidity and hospital stay. These factors decrease
overall hospital costs. It is also easy to recognize any residual
VSDs after closure by echocardiography because the heart is
beating.
Is it possible that you could use your patch technique through
a catheter and avoid CPB, or would you consider using the device,
which will save the patient from CPB?
Dr Olsson. If I may just speculate, I think most patches can be
delivered through catheters in some way or another. I’m not sure
which ones. But I think the important point is that we had 11
patients here with complex lesions who would have been subjected
to CPB anyway; there were only 3 patients with isolated multiple
VSDs.
Dr Amin. The data we have are also combined data with single
muscular VSD and multiple muscular VSDs with weights as low
as 2.9 kg. So these cases were really complicated too, and we used
the device.
Dr Olsson. Yes, I was only referring to those cases of trans-
position.
Dr Brizard. If I may comment, I don’t think those devices can
be introduced into a catheter or delivery sheath. One of the
advantages is obviously the cost. The specially designed devices,
like the Amplatzer device, are much more appropriate for the
delivery through a catheter sheath.
And your technique in which it is delivered through the RV free
wall is extremely appropriate for a single muscular VSD in a
neonate, where the major danger of the procedure is actually
introducing the guide wire from the femoral artery into the heart.
The stiffness of the guidewire and the sheath, going actually
through the RV free wall, allows you to bypass the danger of the
catheter delivery in neonates. The advantages of our technique is
that we address patients that have complex defects as well and that
we have a lower cost.
Dr Carlos Troconis (Caracas, Venezuela). I would like to ask
Dr Olsson to comment on a technique we have used lately on such
cases, which is the introduction of a small-diameter cardioscope
through either the RV or the aortic valve to inspect the LV, identify
the holes, and perhaps use your patch to close them.
Dr Olsson. Yes, I’ve seen that technique reported by Masse
and colleagues in which they introduced the cardioscope through
the aorta to inspect the LV. It is an elegant technique, and I’m sure
it could be useful in selected cases, but we have not seen a
definitive need of it.
The learning curve of performing epicardial echocardiography
is not that steep. You can master it pretty quickly, and once you
have done that, I think it’s no longer useful to use another tech-
nique.
Dr Emile A. Bacha (Chicago, Ill). We now have a series of 6
patients in whom we’ve used the technique of periventricular VSD
closure with a free wall perforation and crossing the VSD with a
wire, with the Amplatzer device, and I think that it is similar to
your technique.
The biggest difference is that you don’t have to crossclamp and
arrest the heart. A lot of our patients also have complex anomalies
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Dthat require CPB, but the advantage is saving yourself 45 minutes
of crossclamp time and being able to check—we use transesoph-
ageal echocardiography and not epicardial real-time cardiogra-
phy—whether you have closed the VSD or not before embarking
on the repair of the other lesions.
I have a technical question for you. In the patients who have
had pulmonary arterial bands with thick trabeculations in the RV
apex, did you find it hard to anchor your patch? This is the group
of patients in which we found it hard to expand the RV disk,
because there simply isn’t enough space in the RV apex to place
these devices.
Dr Olsson. I agree with the issue of CPB.
Regarding the patch, there may be some RV hypertrophy after
the banding, but we haven’t had that as a severe problem.
The patch is composed of two layers, and the septal layer is
composed of thick PTFE felt, which is soft and sort of molded
around the VSD, and an outer layer of knit Dacron polyester
fabric, which is stiffer to prevent the patch from becoming funnel-
shaped when tied down.692 The Journal of Thoracic and Cardiovascular Surgery ● Novedid acknowledge the team of Chicago and their work and their
contributions of the generation of the idea.
Dr Thomas L. Spray (Philadelphia, Pa). Two patients had
heart block, which is 15%; however, most of the VSDs weren’t in
the region of the conduction tissue, and you don’t sew anything.
How does that happen?
Dr Brizard. It is mentioned in the article that we find it
disturbing. One of these patients is now in permanent sinus
rhythm. It was a case of complex transposition with LV outflow
tract obstruction; we did the permanent VSD closure and a resec-
tion of the LV outflow tract obstruction. So there are multiple
reasons for that patient to have a transient heart block.
The second patient had a complex septum with which I had
serious difficulties and that required three crossclamps. This
patient had had a cardiac arrest at 18 postoperative hours. He
was resuscitated and put on extracorporeal membrane oxygen-
ation. He was in second-degree heart block immediately after
the operation, and complete heart block only developed during
the resuscitation. He has remained in complete heart blockDr Brizard. I have no comment, but I would like to say that we since. I have no explanation.mber 2004
